Compounds and compositions as Syk kinase inhibitors

US8722692B2 · kind B2 · utility

Inventors

• Jianwei Che · San Diego, US
• Qiang Ding · San Diego, US
• Xiaohui He · San Diego, US
• Hong Liu · Seattle, US
• Yahua Liu · San Diego, US
• Pierre-Yves Michellys · San Marcos, US
• Barun Okram · San Marcos, US
• Xu Wu · San Diego, US
• Kunyong Yang · San Diego, US
• Xuefeng Zhu · San Diego, US

Key dates

• Filing date: Jul 30, 2010
• Grant date: May 13, 2014
• Expiry date: Oct 19, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are a novel class of compounds of Formula (I),pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated Syk kinase activity.